Publication Name	World Journal of Neurology
Manuscript ID	16451
Country	Greece

Received	2015-01-18 14:52
Peer-Review Started	2015-01-19 14:14
To Make the First Decision	2015-02-07 14:48
Return for Revision	2015-02-10 08:38
Revised	2015-02-14 00:07
Second Decision	2015-02-27 09:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-03-09 17:38
Articles in Press	2015-03-09 17:38
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-26 19:13
Publish the Manuscript Online	2015-03-31 10:53

ISSN	2218-6212 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Neurosciences
Manuscript Type	Editorial
Article Title	Mavridis’ atrophy in Parkinson’s disease-five years later: Future perspectives
Manuscript Source	Invited Manuscript
All Author List	Ioannis N Mavridis and Efstratios-Stylianos Pyrgelis
Funding Agency and Grant Number
Corresponding Author	Ioannis N Mavridis, MD, PhD, Department of Neurosurgery, “K.A.T.-N.R.C.” General Hospital of Attica, Nikis str. 2, Kifissia, 14561 Athens, Greece. pap-van@otenet.gr
Key Words	Parkinson’s disease; Mavridis’ atrophy; Nucleus accumbens; Neuroimaging; Neuropathology; Substantia nigra
Core Tip	Mavridis’ atrophy (MA) is the nucleus accumbens atrophy in Parkinson’s disease (PD). MA begins in early-stage PD patients and is correlated with psychiatric and cognitive PD symptoms. MA is obviously part of the dopaminergic nigrostriatal degeneration that occurs in PD. It would be interesting to have a post-mortem pathological study focused on the nucleus accumbens of parkinsonic individuals. MA as an imaging finding could be a risk factor for the expression and/or severity of specific symptoms. Thus it has to be tested whether the presence of MA is related, for example, with the expression and/or severity of motor PD symptoms.
Publish Date	2015-03-31 10:53
Citation	Mavridis IN, Pyrgelis ES. Mavridis’ atrophy in Parkinson’s disease-five years later: Future perspectives. World J Neurol 2015; 5(1): 1-4
URL	http://www.wjgnet.com/2218-6212/full/v5/i1/1.htm
DOI	http://dx.doi.org/10.5316/wjn.v5.i1.1

Full Article (PDF)	WJN-5-1.pdf
Full Article (Word)	WJN-5-1.doc
Manuscript File	16451-Review.doc
Answering Reviewers	16451-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	16451-Conflict-of-interest statement.pdf
Copyright License Agreement	16451-Copyright assignment.pdf
Peer-review Report	16451-Peer-review(s).pdf
Scientific Misconduct Check	16451-Scientific misconduct check.pdf
Scientific Editor Work List	16451-Scientific editor work list.pdf